Related Articles
Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway Retraction in /10.3892/mmr.2023.12978
Paris saponin II inhibits human ovarian cancer cell‑induced angiogenesis by modulating NF-κB signaling
Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway
Benzo[a]pyrene induces oxidative stress and endothelial progenitor cell dysfunction via the activation of the NF-κB pathway
Tetraarsenic hexoxide demonstrates anticancer activity at least in part through suppression of NF-κB activity in SW620 human colon cancer cells